Characterization of the rat mesangial cell type 2 sulfonylurea receptor-Reference-Cited by-同舟云学术

Characterization of the rat mesangial cell type 2 sulfonylurea receptor

Published:1999-06 Issue:6 Volume:55 Page:2289-2298
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Asano Kenichiro,Cortes Pedro,Garvin Jeffrey L.,Riser Bruce L.,Rodríguez-Barbero Alicia,Szamosfalvi Balázs,Yee Jerry

Publisher

Elsevier BV

Subject

Nephrology

Reference55 articles.

1. Diabetes mellitus in the elderly: Use of sulfonylurea agents in older diabetic patients;Peters;Clin Geriatr Med,1990

2. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. I. Design, methods, and baseline results;University Group Diabetes Program;Diabetes,1970

3. The sulfonylurea receptor;Ashcroft;Biochim Biophys Acta,1992

4. Sulfonylurea-stimulated glucose transport association with diaclyglycerollike activation of protein kinase C in BC3H1 myocytes;Cooper;Diabetes,1990

5. Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: Effect of chronic insulin and tolbutamide treatment;Tordjman;Proc Natl Acad Sci USA,1989

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DTI-SNNFRA: Drug-target interaction prediction by shared nearest neighbors and fuzzy-rough approximation;PLOS ONE;2021-02-19

2. Comparison between the effect of glibenclamide and captopril on experimentally induced diabetic nephropathy in rats;Journal of the Renin-Angiotensin-Aldosterone System;2012-10-17

3. Glibenclamide Induces Collagen IV Catabolism in High Glucose-Stimulated Mesangial Cells;Experimental Diabetes Research;2012

4. Glibenclamide prevents increased extracellular matrix formation induced by high glucose concentration in mesangial cells;American Journal of Physiology-Renal Physiology;2007-01

5. Effects of sulfonylureas, α-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes;Kidney International;2005-02